As of December 2024, ProMIS Neurosciences has a market cap of $17.56M. This makes ProMIS Neurosciences the world's 4929th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $33.43M | 53.91% |
2023 | $21.72M | -73.50% |
2022 | $81.96M | -36.46% |
2021 | $128.99M | 37.42% |
2020 | $93.86M | -37.72% |
2019 | $150.70M | -33.17% |
2018 | $225.49M | 17.75% |
2017 | $191.50M | 65.69% |
2016 | $115.58M | 179.45% |
2015 | $41.36M | -74.83% |
2014 | $164.30M | -56.19% |
2013 | $375.06M | -15.78% |
2012 | $445.32M | 48.12% |
2011 | $300.65M | -32.80% |
2010 | $447.39M | -27.93% |
2009 | $620.76M | 20.40% |
2008 | $515.57M | -62.40% |
2007 | $1.37B | 0.83% |
2006 | $1.36B | - |